Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice

References

• Alt V, Bechert T, Steinrucke P, et al. (2004). An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 25:4383–91
   PubMed Web of Science ®Google Scholar
• Bouin P. (1897). Phenomenes Cytologique anoramaux dans. I’Histogenes, Nancy
   Google Scholar
• Castellano JJ, Shafii SM, Ko F, et al. (2007). Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int wound J 4:114–22
   PubMedGoogle Scholar
• Errington RJ, Brown MR, Silvestre OF, et al. (2010). Single cell nanoparticle tracking to model cell cycle dynamics and compartmental inheritance. Cell Cycle 9:121–30
   PubMed Web of Science ®Google Scholar
• Florence AT. (1997). The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharmaceut Res 14:259–66
   PubMed Web of Science ®Google Scholar
• Florence AT, Hussain N. (2001). Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev 50:S69–89
   PubMed Web of Science ®Google Scholar
• Huang Z, Jiang X, Guo D, Gu N. (2011). Controllable synthesis and biomedical applications of silver nanomaterials. J Nanosci Nanotechnol 11:9395–408
   PubMed Web of Science ®Google Scholar
• Hussain N, Jaitley V, Florence AT. (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50:107–42
   PubMed Web of Science ®Google Scholar
• Jeong GN, Jo UB, Ryu HY, et al. (2010). Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague–Dawley rats. Arch Toxicol 84:63–9
   PubMed Web of Science ®Google Scholar
• Kawata K, Osawa M, Okabe S. (2009). In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046–51
   PubMed Web of Science ®Google Scholar
• Kim JA, Åberg C, Salvati A, Dawson KA. (2012). Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7:62–8
   Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, et al. (2010). Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20–31
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, et al. (2011). Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18–42
   PubMed Web of Science ®Google Scholar
• Martinez-Gutierrez F, Olive PL, Banuelos A, et al. (2010). Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomed-Nanotechnol 6:681–8
   PubMed Web of Science ®Google Scholar
• Nersisyan HH, Lee JH, Son HT, et al. (2003). A new and effective chemical reduction method for preparation of nanosized silver powder and colloid dispersion. Mater Res Bull 38:949–56
   Web of Science ®Google Scholar
• Nikaido H, Vaara M. (1985). Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1–32
   PubMedGoogle Scholar
• Oberdörster G, Maynard A, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group, et al. (2005). Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
   PubMed Web of Science ®Google Scholar
• Panáček A, Kvitek L, Prucek R, et al. (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem 110:16248–53
   PubMed Web of Science ®Google Scholar
• Peters A, Wichmann HE, Tuch T, et al. (1997). Respiratory effects are associated with the number of ultrafine particles. Am J of Resp Crit Care 155:1376–83
   PubMed Web of Science ®Google Scholar
• Raetz CRH. (1990). Biochemistry of endotoxins. Annu Rev of Biochem 59:129–70
   PubMed Web of Science ®Google Scholar
• Richard JW III, Spencer BA, McCoy LF, et al. (2002). Acticoat versus silver ion: the truth. J Burns Wound Care (Renamed as ePlasty) 1:11–20
   Google Scholar
• Shrivastava S, Bera T, Roy A, et al. (2007). Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18:225103–12
   Web of Science ®Google Scholar
• Shrivastava S, Bera T, Singh SK, et al. (2009). Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 3:1357–64
   PubMed Web of Science ®Google Scholar
• Silva MT, Sousa JCF. (1973). Ultrastructure of the cell wall and cytoplasmic membrane of gram-negative bacteria with different fixation techniques. J Bacteriol 113:953–62
   PubMed Web of Science ®Google Scholar
• Sondi I, Salopek-Sondi B. (2004). Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–82
   PubMed Web of Science ®Google Scholar
• Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. (2002). Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679–86
   Web of Science ®Google Scholar
• Summers HD. (2012). Nanoparticles in the life of a cell. Nat Nanotechnol 7:9–10
   Web of Science ®Google Scholar
• Summers HD, Rees P, Holton MD, et al. (2011). Statistical analysis of nanoparticle closing in a dynamic cellular system. Nat Nanotechnol 6:170–4
   PubMed Web of Science ®Google Scholar
• Tang J, Xiong L, Wang S, et al. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9:4924–32
   PubMed Web of Science ®Google Scholar
• Tang J, Xiong L, Zhou G, et al. (2010). Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 10:6313–17
   PubMed Web of Science ®Google Scholar
• Xing ZC, Chae WP, Huh MW, et al. (2011). In vitro anti-bacterial and cytotoxic properties of silver-containing poly(L-lactide-co-glycolide) nanofibrous scaffolds. J Nanosci Nanotechnol 11:61–5
   PubMed Web of Science ®Google Scholar